LY2062430

LY2062430 Uses, Dosage, Side Effects, Food Interaction and all others data.

LY2062430 is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.

Trade Name LY2062430
Generic Solanezumab
Solanezumab Other Names LY2062430, Solanezumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
LY2062430
LY2062430

Innovators Monograph

You find simplified version here LY2062430

*** Taking medicines without doctor's advice can cause long-term problems.
Share